It is a pharma private limited company based in Indore, Madhya Pradesh, India, established in 2016.
2016 | Indore, Madhya Pradesh, India | ActiveNextgen Pharmaceutical And Formulations Private Limited, a active private limited company, was established on 09 March 2016 in Indore, Madhya Pradesh, India. Engaging in pharmaceutical retailers & distributors within the manufacturing sector, it holds CIN: U24230MP2016PTC035508. Registered under ROC Roc Gwalior. it is unlisted. It has an authorized capital of ₹0.90 M and a paid-up capital of ₹0.30 M.
It upholds a compliant status. Its leadership includes Vikrant Mansana (Director), Meenakshi Shrimali (Director), Rajesh Verma (Director). Past directors included Vikrant Mansana, Meenakshi Shrimali, Jayati Kumar Choudhary. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 116 /A, Surya Dev Nagar,, Indore, Madhya Pradesh, 452009.
U24230MP2016PTC035508
035508
09 March 2016
₹0.90 M
₹0.30 M
Roc Gwalior
Unlisted
Active
Explore comprehensive insights into Nextgen Pharmaceutical And Formulations Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vikrant Mansana | Director | 22 Mar 2024 | Current |
| Meenakshi Shrimali | Director | 22 Mar 2024 | Current |
| Rajesh Verma | Director | 09 Mar 2016 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 29 Sep 2024 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2024 | Past |
| Pramod Abcsdd | Director | 17 Aug 2021 | Past |
| Pramod Abcsdd | Director | 28 Mar 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Nextgen Pharmaceutical And Formulations Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 26.51% decrease. The company also saw a substantial fall in profitability, with a 85.73% decrease in profit. The company's net worth moved up by a moderate rise of 0.7%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Nextgen Pharmaceutical And Formulations had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Nextgen Pharmaceutical And Formulations, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Nextgen Pharmaceutical And Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nextgen Pharmaceutical And Formulations's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Nextgen Pharmaceutical And Formulations Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on Nextgen Pharmaceutical And Formulations Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Gwalior. was documented.
Progress on Vikrant Mansana was appointed as a Director was appointed as a Director on 22 Mar 2024 & has been associated with this company since 1 year 8 months . was documented.
Progress on Meenakshi Shrimali was appointed as a Director was appointed as a Director on 22 Mar 2024 & has been associated with this company since 1 year 8 months . was documented.
Progress on Rajesh Verma was appointed as a Director was appointed as a Director on 09 Mar 2016 & has been associated with this company since 9 years 9 months . was documented.
Progress on Nextgen Pharmaceutical And Formulations Private Limited was registered on 09 Mar 2016 with Roc Gwalior & aged 9 years 9 months as per MCA records. was documented.
The CIN of Nextgen Pharmaceutical And Formulations Private Limited is U24230MP2016PTC035508.
Nextgen Pharmaceutical And Formulations Private Limited is headquartered at 116 /A, Surya Dev Nagar,, Indore, Madhya Pradesh, 452009.
Nextgen Pharmaceutical And Formulations Private Limited was incorporated on 09 March 2016.
The current directors of Nextgen Pharmaceutical And Formulations Private Limited are
The primary industry of Nextgen Pharmaceutical And Formulations Private Limited is Manufacturing.
Nextgen Pharmaceutical And Formulations Private Limited is unlisted.
The authorized capital of Nextgen Pharmaceutical And Formulations Private Limited is ₹0.90 M, and the paid-up capital is ₹0.30 M.
The compliance status of Nextgen Pharmaceutical And Formulations Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX